Physician profile
Bruce P Theall
NPI 1831187434
$312.25
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $60.09 · 2021: $57.11.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $66.85 | 2019 | |
| Bioventus LLC | $62.43 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $41.20 | 2019 | |
| Alfasigma USA, INC. | $35.81 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $32.90 | 2021 | |
| Kci USA, INC. | $17.65 | 2020 | |
| Abbott Laboratories | $17.59 | 2019 | |
| Horizon Therapeutics Plc | $13.26 | 2019 | |
| Smith+Nephew, INC. | $12.39 | 2019 | |
| Integra Lifesciences Corporation | $12.17 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Theall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.